These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20798464)

  • 21. Development of a novel nonviral gene silencing system that is effective both in vitro and in vivo by using a star-shaped block copolymer (star vector).
    Mori T; Ishikawa A; Nemoto Y; Kambe N; Sakamoto M; Nakayama Y
    Bioconjug Chem; 2009 Jun; 20(6):1262-9. PubMed ID: 19456093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes.
    Al-Jamal KT; Toma FM; Yilmazer A; Ali-Boucetta H; Nunes A; Herrero MA; Tian B; Eddaoudi A; Al-Jamal WT; Bianco A; Prato M; Kostarelo K
    FASEB J; 2010 Nov; 24(11):4354-65. PubMed ID: 20647548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA interference by nanofiber-based siRNA delivery system.
    Cao H; Jiang X; Chai C; Chew SY
    J Control Release; 2010 Jun; 144(2):203-12. PubMed ID: 20138939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
    Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
    Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling RNA interference (RNAi)-mediated toxicity in neural cultures for effective short interfering RNA design.
    Read ML; Mir S; Spice R; Seabright RJ; Suggate EL; Ahmed Z; Berry M; Logan A
    J Gene Med; 2009 Jun; 11(6):523-34. PubMed ID: 19322910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium.
    Santel A; Aleku M; Keil O; Endruschat J; Esche V; Fisch G; Dames S; Löffler K; Fechtner M; Arnold W; Giese K; Klippel A; Kaufmann J
    Gene Ther; 2006 Aug; 13(16):1222-34. PubMed ID: 16625243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable polymer-mediated sh/siRNA delivery for cancer studies.
    Jere DJ; Cho CS
    Methods Mol Biol; 2010; 623():243-69. PubMed ID: 20217556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors.
    Singh R; Pantarotto D; McCarthy D; Chaloin O; Hoebeke J; Partidos CD; Briand JP; Prato M; Bianco A; Kostarelos K
    J Am Chem Soc; 2005 Mar; 127(12):4388-96. PubMed ID: 15783221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.
    Ebadi P; Karimi MH; Pourfathollah AA; Saheb Ghadam Lotfi A; Soheili ZS; Samiee S; Hajati S; Nadali F; Geramizadeh B; Moazzeni SM
    Iran J Immunol; 2009 Mar; 6(1):1-11. PubMed ID: 19293472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. siRNA stabilization prolongs gene knockdown in primary T lymphocytes.
    Mantei A; Rutz S; Janke M; Kirchhoff D; Jung U; Patzel V; Vogel U; Rudel T; Andreou I; Weber M; Scheffold A
    Eur J Immunol; 2008 Sep; 38(9):2616-25. PubMed ID: 18792414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Specific inhibition of HER-2 expression in ovarian carcinoma cells by siRNA targeting HER-2].
    Lu YM; Zhang SL; Meng LR; Zhao YY
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):619-23. PubMed ID: 16681908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfection of "naked" siRNA results in endosomal uptake and metabolic impairment in cultured neurons.
    Lingor P; Michel U; Schöll U; Bähr M; Kügler S
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1126-33. PubMed ID: 14985130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells.
    Brito JL; Davies FE; Gonzalez D; Morgan GJ
    J Immunol Methods; 2008 Apr; 333(1-2):147-55. PubMed ID: 18299137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation.
    Prechtel AT; Turza NM; Theodoridis AA; Kummer M; Steinkasserer A
    J Immunol Methods; 2006 Apr; 311(1-2):139-52. PubMed ID: 16556448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Covalently Functionalized of Single-Walled Carbon Nanotubes by DSPE-PEG-PEI for SiRNA Delivery.
    Siu KS; Zhang Y; Zheng X; Koropatnick J; Min WP
    Methods Mol Biol; 2016; 1364():151-63. PubMed ID: 26472449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Meade BR; Dowdy SF
    Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
    He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
    Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.